CDH2 and carcinoma: One of the cellular hallmarks of carcinoma malignancy and aggressiveness is epithelial to mesenchymal transition (EMT), which involves the remodeling of adhesion molecules, with epithelial E-cadherin downregulated and replaced by N-cadherin and/or vimentin [28].